mgh_logo

Harvard-Medical-School-logo

Generic filters

menopausal transition

Meta-Analysis:  Acupuncture Effective for Menopausal Vasomotor Symptoms

Over the last decade, various studies have evaluated the effectiveness of acupuncture for the treatment of menopausal vasomotor symptoms.  In a recent meta-analysis, studies that reported on the frequency or severity of hot flashes, menopause-related symptoms assessed using the Menopause Rating Scale (MRS), and quality of life (QoL) assessed using the Menopause-Specific Quality of Life (MSQoL) questionnaire were included.  Twelve studies with a total of 869 participants met the inclusion criteria and were included in the final analysis.

By |2015-07-08T13:32:58-04:00April 17th, 2015|Alternative & Complementary, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Meta-Analysis:  Acupuncture Effective for Menopausal Vasomotor Symptoms
Read More

Menopausal Vasomotor Symptoms Last Longer than Five Years for Most Women

Up to 80% of women experience vasomotor symptoms (VMS) as they transition into the menopause phase. While clinical guidelines suggest that VMS typically last from 6 months to 2 years, we often see women with VMS lasting for a much longer period of time. To more accurately assess the duration of VMS in perimenopausal women, researchers analyzed data from 1449 women included in the Study of Women's Health Across the Nation (SWAN), an observational study of women entering menopause.  Here is a summary of the key findings:

By |2015-02-25T12:02:26-04:00February 25th, 2015|Menopausal Symptoms, Vasomotor Symptoms|Comments Off on Menopausal Vasomotor Symptoms Last Longer than Five Years for Most Women
Read More

Low Dose Paroxetine Improves Sleep in Postmenopausal Symptoms

Last year, the FDA approved the first non-hormonal treatment for hot flashes – a 7.5-mg formulation of the selective serotonin reuptake inhibitor (SSRI) paroxetine which was marketed under the name of Brisdelle. A new study [...]

By |2018-06-09T17:53:30-04:00August 25th, 2014|Medication, Menopausal Symptoms, Sleep Disorders, Treatment|Comments Off on Low Dose Paroxetine Improves Sleep in Postmenopausal Symptoms
Read More

FDA Approves Nonhormonal Drug for Hot Flashes: Low-Dose Paroxetine to be Marketed as Brisdelle

The FDA recently approved a 7.5-mg formulation of the selective serotonin reuptake inhibitor (SSRI) paroxetine mesylate for the treatment of hot flashes.   It will be marketed under the name of Brisdelle.

By |2015-08-06T09:25:00-04:00July 15th, 2013|Menopausal Symptoms, Vasomotor Symptoms|Comments Off on FDA Approves Nonhormonal Drug for Hot Flashes: Low-Dose Paroxetine to be Marketed as Brisdelle
Read More

Weight Loss and a Low-Fat Diet Help to Reduce Hot Flashes in Menopausal Women

Various studies have shown that women with a higher body mass index (BMI) or a higher percent of body fat have more frequent or more severe menopausal symptoms.  In a recent study, researchers evaluated the impact of a low-fat diet on vasomotor symptoms in a group of 17,473 postmenopausal women between the ages of 50 and 79.

By |2015-08-12T12:19:50-04:00August 8th, 2012|Alternative & Complementary, Menopausal Symptoms, Prevention, Vasomotor Symptoms|Comments Off on Weight Loss and a Low-Fat Diet Help to Reduce Hot Flashes in Menopausal Women
Read More

New Research from the CWMH: Surgically Induced Menopause No Worse than Natural in Terms of Risk for Depression, Anxiety

Each year about 600,000 women in the United States undergo a hysterectomy.  Somewhere between 55% and 80% of these women who also have their ovaries removed along with the uterus—a procedure known as oophorectomy.  After the removal of the ovaries, menopause follows immediately and is associated with a constellation of symptoms including hot flashes and insomnia, as well as depression and anxiety. 

By |2016-03-28T13:02:53-04:00August 2nd, 2012|Depressive Disorders, Menopausal Symptoms, Prevalence & Risk Factors, Research at CWMH|Comments Off on New Research from the CWMH: Surgically Induced Menopause No Worse than Natural in Terms of Risk for Depression, Anxiety
Read More
Copyright 2026 MGH Center for Women's Mental Health | All Rights Reserved
Go to Top